The State of Texas Top Legal Officer Takes Legal Action Against Acetaminophen Producers Regarding Autism Claims

Courtroom Proceedings
Ken Paxton, who supports former President Trump seeking election to US Senate, accused pharmaceutical manufacturers of concealing potential dangers of Tylenol

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, claiming the companies hid safety concerns that the medication created to children's neurological development.

This legal action comes four weeks after Donald Trump advocated an unproven link between taking acetaminophen - also known as acetaminophen - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which presently makes it.

In a declaration, he said they "deceived the public by making money from pain and promoting medication regardless of the risks."

Kenvue asserts there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of paracetamol and the likely effects that could have on the health of American women and children."

On its website, the company also mentioned it had "consistently assessed the pertinent research and there is no credible data that shows a verified association between taking paracetamol and autism spectrum disorder."

Organizations speaking for medical professionals and medical practitioners agree.

The leading OB-GYN organization has declared paracetamol - the main ingredient in Tylenol - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can create serious health risks if ignored.

"In multiple decades of studies on the utilization of paracetamol in pregnancy, zero credible investigations has successfully concluded that the use of acetaminophen in any period of pregnancy causes neurological conditions in children," the association commented.

The court filing mentions latest statements from the previous government in asserting the drug is allegedly unsafe.

Last month, the former president raised alarms from public health officials when he instructed women during pregnancy to "fight like hell" not to use acetaminophen when ill.

The FDA then released a statement that doctors should think about restricting the consumption of acetaminophen, while also declaring that "a proven link" between the medication and autism in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had vowed in spring to conduct "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a short period.

But experts cautioned that identifying a sole reason of autism - thought by researchers to be the consequence of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a type of enduring cognitive variation and condition that influences how persons perceive and engage with the world, and is identified using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is running for US Senate - alleges Kenvue and J&J "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "remove any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit echoes the complaints of a collection of mothers and fathers of minors with autism and ADHD who filed suit against the producers of acetaminophen in 2022.

A federal judge rejected the legal action, stating studies from the plaintiffs' authorities was inconclusive.

Melissa Meza
Melissa Meza

A tech enthusiast and writer passionate about sharing innovative solutions and fostering community growth through insightful content.

June 2025 Blog Roll

Popular Post